CC BY-NC-ND 4.0 · Sleep Sci 2021; 14(03): 291-295
DOI: 10.5935/1984-0063.20200077
CASE REPORTS

Resolution of fibromyalgia by controlling obstructive sleep apnea with a mandibular advancement device

Fernanda Vantine
1   Universidade do Vale do Paraíba, Dental School - São José dos Campos - São Paulo - Brazil.
,
Dominik Ettlin
2   University of Zurich, Center of Dental Medicine - Zurich - Zurich - Switzerland.
4   Faculdade São Leopoldo Mandic, Laboratory of Neuroimmune Interface of Pain Research - Campinas - São Paulo - Brazil.
,
Miguel Meira-e-Cruz
3   Centro Cardiovascular da Universidade de Lisboa, Lisbon School of Medicine, Sleep Unit - Lisboa - Lisboa - Portugal.
› Author Affiliations

ABSTRACT

Fibromyalgia (FM) is a chronic, often disabling disorder characterized by multisite pain along with sleep problems and fatigue. Pain and sleep exhibit a reciprocal relationship. When FM and obstructive sleep apnea/hypopnea (OSA) co-exist, treatment options include continuous positive airway pressure or mandibular advancement device. We present a patient experiencing fibromyalgia and OSA whose symptoms vanished wearing a Mandibular Advancement Device (MAD) during sleep. To our knowledge, this is the first documented case of FM symptom resolution by MAD treatment.



Publication History

Received: 04 June 2020

Accepted: 13 November 2020

Article published online:
30 November 2023

© 2021. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • REFERENCES

  • 1 Arnold L, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019 Jun;20(6):611-28.
  • 2 Gustorff B, Dorner T, Likar R, Gridold W, Lawrence K, Schwarz F, et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand. 2008 Jan;52(1):132-6.
  • 3 Wu YL, Chang LY, Lee HC, Fang SC, Tsai PS. Sleep disturbances in fibromyalgia: a meta-analysis of case-control studies. J Psychosom Res. 2017 May;96:89-97.
  • 4 Mork PJ, Nilsen TIL. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum. 2012 Jan;64(1):281-4.
  • 5 Davies K, Macfarlane GF, Nicholl BI, Dickens C, Morriss R, Ray D, et al. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology (Oxford). 2008 Dec;47(12):1809-13.
  • 6 Andersen ML, Araujo P, Frange C, Tufik S. Sleep disturbance and pain: a tale of two common problems. Chest. 2018 Nov;154(5):1249-59.
  • 7 Meresh ES, Artin H, Joyce C, Birch C, Daniels D, Owens JH, et al. Obstructive sleep apnea co-morbidity in patients with fibromyalgia: a single-center retrospective analysis and literature review. Open Access Rheumatol. 2019;11:103-9.
  • 8 Aytekin E, Demir SE, Komut EA, Okur SC, Burnaz O, Caglar NS, et al. Chronic widespread musculoskeletal pain in patients with obstructive sleep apnea syndrome and the relationship between sleep disorder and pain level, quality of life, and disability. J Phys Ther Sci. 2015 Sep;27(9):2951-4.
  • 9 May KP, West SG, Baker MR, Everett DW. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med. 1993 May;94(5):505-8.
  • 10 Mundt JM, Eisenschenk S, Robinson ME. An examination of pain's relationship to sleep fragmentation and disordered breathing across common sleep disorders. Pain Med. 2018 Aug;19(8):1516-24.
  • 11 Marvisi M, Balzarini L, Mancini C, Ramponi S, Marvisi C. Fibromyalgia is frequent in obstructive sleep apnea and responds to CPAP therapy. Eur J Intern Med. 2015 Nov;26(9):e49-50.
  • 12 Mehrtash M, Bakker JP, Ayas N. Predictors of continuous positive airway pressure adherence in patients with obstructive sleep apnea. Lung. 2019 Apr;197(2):115-21.
  • 13 Canadian Agency for Drugs and Technologies in Health (CADTH). CPAP treatment for adults with obstructive sleep apnea: review of the clinical and cost-effectiveness and guidelines. Ottawa: CADTH; 2013.
  • 14 Dieltjens M, Vanderveken O. Oral appliances in obstructive sleep apnea. Healthcare (Basel). 2019 Nov;7(4):141.
  • 15 Kuhn E, Schwarz EI, Bratton DJ, Rossi VA, Kohler M. Effects of CPAP and mandibular advancement devices on health-related quality of life in OSA: a systematic review and meta-analysis. Chest. 2017 Apr;151(4):786-94.
  • 16 Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015 Dec;314(21):2280-93.
  • 17 Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan SF, et al. AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med. 2017 May;13(5):665-6.
  • 18 Langley GB, Sheppeard H. The visual analogue scale: Its use in pain measurement. Rheumatol Int. 1985;5(4):145-8.
  • 19 Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res. 2011 Nov;63(Suppl 11):S240-S52.
  • 20 Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep.1991 Dec;14(6):50-5.
  • 21 Bertolazi AN, Fagondes SC, Hoff LS, Pedro VD, Barreto SSM, Johns MW. Portuguese-language version of the Epworth sleepiness scale: validation for use in Brazil. J Bras Pneumol. 2009;35(9):877-83.
  • 22 Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120.
  • 23 Marques AP, Santos AMB, Assumpção A, Matsutani LA, Lage LV, Pereira CAB. Validação da versão brasileira do fibromyalgia impact questionnaire (FIQ). Rev Bras Reumatol. 2006 Feb;46(1):24-31.
  • 24 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.
  • 25 Santos IS, Tavares BF, Munhoz TN, Almeida LSP, Silva NTB, Tams BD, et al. Sensibilidade e especificidade do patient health questionnaire-9 (PHQ-9) entre adultos da população geral. Cad Saúde Pública. 2013 Aug;29(8):1533-43.
  • 26 Schwarz MJ, Offenbaecher M, Neumeister A, Ewert T, Willeit M, Praschak-Rieder N, et al. Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis. 2002 Dec;11(3):434-42.
  • 27 Hilaire G, Voituron N, Menuet C, Ichiyama RM, Subramanian HH, Dutschmann. The role of serotonin in respiratory function and dysfunction. Respir Physiol Neurobiol. 2010 Nov;174(1-2):76-88.
  • 28 Cheng JY. Serotonin reuptake inhibitors in obstructive sleep apnea: associations in people with and without epilepsy. Neurol Res Int. 2018 Aug;2018:7247605.
  • 29 Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia and allied syndromes. Joint Bone Spine. 2008 Jul;75(4):397-402.
  • 30 Chiu YC, Hu HY, Lee FP, Huang HM. Tension-type headache associated with obstructive sleep apnea: a nationwide population-based study. J Headache Pain. 2015;16:34.
  • 31 Suzuki K, Miyamoto M, Miyamoto T, Numao A, Suzuki S, Sakuta H, et al. Sleep apnoea headache in obstructive sleep apnoea syndrome patients presenting with morning headache: comparison of the ICHD-2 and ICHD-3 beta criteria. J Headache Pain. 2015;16:56.
  • 32 Kim J, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK. Excessive daytime sleepiness is associated with an exacerbation of migraine: a population-based study. J Headache Pain. 2016 Dec;17(1):62.
  • 33 Wu J, Li P, Wu X, Chen W. Chronic intermittent hypoxia decreases pain sensitivity and increases the expression of HIF1a and opioid receptors in experimental rats. Sleep Breath. 2015 May;19(2):561-8.
  • 34 Smith M, Perlis ML, Smith MS, Giles DE, Carmody TP. Sleep quality and presleep arousal in chronic pain. J Behav Med. 2000 Feb;23(1):1-13.
  • 35 Meira e Cruz M, Manetta IP. Sleep and pain: a circadian multi-challenge rather than a simple bidirectional pathway. Br J Pain. 2019 Jul/Sep;2(3):303-4.
  • 36 Lucchesi LM, Pradella-Hallinan M, Lucchesi M, Moraes WAS. Sleep in psychiatric disorders. Rev Bras Psiquiatr. 2005;27(Supl I):27-32.
  • 37 Robinson TD, Grundstein RR. Sleep-disordered breathing. In: Eckel RH, ed. Obesity - mechanisms and clinical management. New York: Lippincott Williams & Wilkins; 2003. p. 202-28.
  • 38 Brooks LJ, Strohl KP. Size and mechanical properties of the pharynx in health men and women. Am Rev Respir Dis. 1992;146:1394-7.
  • 39 Krystal A, Edinger J, Wohlgemuth W, Marsh GR. Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev. 1998 Nov;2(4):243-53.
  • 40 Meira e Cruz M, Gozal D. Slow-wave sleep loss and cardiometabolic dysfunction: androgenic hormone secretion as a critical intermediate mediator. Sleep Med. 2020 Feb;66:82-4. DOI: https://doi.org/10.1016/j.sleep.2019.08.012
  • 41 Su CH, Chen JH, Lan JL, Wang YC, Tseng CH, Hsu CY, et al. increased risk of coronary heart disease in patients with primary fibromyalgia and those with concomitant comorbidity - a Taiwanese population-based cohort study. PLoS One. 2015;10(9):e0137137. DOI: https://doi.org/10.1371/journal.pone.0137137
  • 42 Sepici V, Tosun A, Köktürk O. Obstructive sleep apnea syndrome as an uncommon cause of fibromyalgia: a case report. Rheumatol Int. 2007 Nov;28(1):69-71.